Form 4: Director Clyde Hosein Increases Stake in Dentsply Sirona

Director Clyde Hosein acquired 6,500 shares of Dentsply Sirona common stock at a price of $9.985 per share.

Summary

• Director Clyde Hosein purchased 6,500 shares of Dentsply Sirona (XRAY) common stock.
• The transaction occurred on June 15, 2026.
• The purchase price was $9.985 per share.
• Following this transaction, the director's total beneficial ownership increased to 70,575.456 shares.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, as director-level insider buying typically indicates confidence in the company's future prospects.

Positives

• Insider confidence is demonstrated by a director purchasing shares with personal capital.
• The acquisition increases the alignment of interests between the director and shareholders.

Negatives

• None identified in this filing.

Risks

• Market volatility affecting the value of the director's equity holdings.

Future Outlook

Not applicable as this is a disclosure of an insider transaction.

Industry Context

StockSavvy.ai notes that insider buying is generally viewed as a positive signal by the market, suggesting that leadership believes the current share price may be undervalued or that they have confidence in the company's long-term strategic direction.

Comparison to Industry Standards

• Insider purchases by board members are standard corporate governance practices and are generally viewed favorably by institutional investors as a sign of commitment.

Stakeholder Impact

• Shareholders may interpret this purchase as a vote of confidence from the board of directors.

Key Dates

Keywords

Dentsply Sirona, XRAY, Insider Trading, Form 4, Director Purchase, Clyde Hosein